Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs Intravenous Milrinone in Cardiac Surgery
NCT04484675Phase 4Recruiting
- Sponsor
- Zagazig University
- Start
- May 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of milrinone in pulmonary hypertension (PH) (2 arms), sponsored by Zagazig University. Primary endpoint: Mean Arterial Pressure. Started May 2023; status: recruiting.
02
Drugs
milrinone
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT04484675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484675.